1-4 of 4
Daniel P. Gale
Close
Sort by
Journal Articles

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

David Kavanagh, Sarah McGlasson, Alexa Jury, Jac Williams, Neil Scolding, Chris Bellamy, Claudia Gunther, Diane Ritchie, Daniel P. Gale, Yashpal S. Kanwar, Rachel Challis, Holly Buist, James Overell, Belinda Weller, Oliver Flossmann, Mark Blunden, Eric P. Meyer, Thomas Krucker, Stephen J. W. Evans, Iain L. Campbell, Andrew P. Jackson, Siddharthan Chandran, David P. J. Hunt
Journal: Blood
Blood (2016) 128 (24): 2824–2833.
https://doi.org/10.1182/blood-2016-05-715987
Published: 2016
Includes: Supplemental data
Journal Articles

Identification Of aHUS and Complement Mutations In Patients Presenting With Acute Thrombotic Microangiopathy

Elizabeth H Phillips, MD, John Connolly, MD, John-Paul Westwood, MD, Siobhan McGuckin, Daniel P Gale, MD, Tim H. J. Goodship, MD, David Kavanagh, MD, Marie A Scully, MD
Journal: Blood
Blood (2013) 122 (21): 1073.
https://doi.org/10.1182/blood.V122.21.1073.1073
Published: 2013
Journal Articles

Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension

Jonathan Bond, Daniel P. Gale, Thomas Connor, Stuart Adams, Jasper de Boer, Duncan M. Gascoyne, Owen Williams, Patrick H. Maxwell, Philip J. Ancliff
Journal: Blood
Blood (2011) 117 (13): 3699–3701.
https://doi.org/10.1182/blood-2010-12-327569
Published: 2011
Journal Articles

Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 α mutation

Daniel P. Gale, Sarah K. Harten, Cecil D. L. Reid, Edward G. D. Tuddenham, Patrick H. Maxwell
Journal: Blood
Blood (2008) 112 (3): 919–921.
https://doi.org/10.1182/blood-2008-04-153718
Published: 2008